Ten-year survival and recurrence of hepatocellular cancer

Abstract

Aim: Long-term survival after hepatocellular cancer (HCC) is difficult to achieve likely related to recurrence. This study aimed to identify factors that were predictive of 10-year survival after the diagnosis of HCC.

Methods: In a prospectively collected database of 1374 HCC cases (1993-2019), we identified 70 patients who survived over 10 years regardless of treatment. We then identified 164 patients in the entire cohort who either had liver resection or transplant, and died before 10 years. Demographics, tumor characteristics, treatment, recurrence and treatment of recurrence were compared.

Results: Of the 10-year survivors, 36 underwent transplant, 27 had liver resection and 7 patients had only locoregional therapy. Compared to the non-survivors, the 10-year survivors were younger and had fewer comorbidities or recurrence, smaller tumor size, lower AST, ALT, AFP, platelets, neutrophil-to-lymphocyte ratio. Multivariate analysis showed only age and diabetes to be negative predictors. Recurrence occurred in 24 survivors (34.3%) with mean time to recurrence with standard deviation 57.1 ± 42.6 months compared to 80 non-survivors (48.7%) with mean time to recurrence of 15.3 ± 14.8 months. For hepatic resection, 10-year survivors had longer time to recurrence compared to non-survivors (median: 31.3 months).

Conclusion: Long-term survivors mostly occur after resection or transplant, but 10% of our cohort survived 10 years with only locoregional therapy. Underlying health status maybe an important predictor of 10-year survival for patients receiving liver resections. Recurrence of HCC occurs in both 10-year survivors and non-survivors, but later recurrence with aggressive treatment of the recurrence may allow for 10-year survival.

Keywords

Hepatocellular cancer / 10-year survival / liver transplantation / hepatic resection

References

[1] Bray F,Soerjomataram I,Torre LA.Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries..CA Cancer J Clin2018;68:394-424

[2] White DL,Kanwal F,El-Serag HB.Incidence of hepatocellular carcinoma in all 50 united states, from 2000 through 2012..Gastroenterology2017;152:812-20 PMCID:PMC5346030

[3] Heimbach JK,Finn RS,Abecassis MM.AASLD guidelines for the treatment of hepatocellular carcinoma..Hepatology2018;67:358-80

[4] Herrero JI,Pardo F,Iñarrairaegui M.Liver transplantation in patients with hepatocellular carcinoma across Milan criteria..Liver Transpl2008;14:272-8

[5] Altekruse SF,Dickie LA.Hepatocellular carcinoma confirmation, treatment, and survival in surveillance, epidemiology, and end results registries, 1992-2008..Hepatology2012;55:476-82 PMCID:PMC3868012

[6] Singal AG,Tiro J.Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis..PLoS Med2014;11:e1001624 PMCID:PMC3972088

[7] Tabrizian P,Shrager B,Roayaie S.Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis..Ann Surg2015;261:947-55

[8] Fernandez-Sevilla E,Selten J,Vibert E.Recurrence of hepatocellular carcinoma after liver transplantation: is there a place for resection?.Liver Transpl2017;23:440-7

[9] Chagas AL,Diniz MA,Mattos AA.Hepatocellular carcinoma recurrence after liver transplantation in a brazilian multicenter study: clinical profile and prognostic factors of survival..Eur J Gastroenterol Hepatol2019;31:1148 PMCID:PMC6687037

[10] Foerster F,Vollmar J,Weinmann A.Long-term observation of hepatocellular carcinoma recurrence after liver transplantation at a European transplantation centre..United Eur Gastroenterol J2019;7:838-49 PMCID:PMC6620871

[11] Zhang JA,Wong LL.Late recurrence of hepatocellular carcinoma after liver transplantation..Hepatoma Res2017;3:58-66 PMCID:PMC5619866

[12] Alshahrani AA,Hwang S,Kim KH.Clinical features and surveillance of very late hepatocellular carcinoma recurrence after liver transplantation..Ann Transplant2018;23:659-65 PMCID:PMC6255332

[13] Xu XF,Han J,Lau WY.Risk factors, patterns, and outcomes of late recurrence after liver resection for hepatocellular carcinoma: a multicenter study from china..JAMA Surg2019;154:209-17 PMCID:PMC6439634

[14] Chen PC,Su CW,Hou MC.Albumin-bilirubin grade may determine the outcomes of patients with very early stage hepatocellular carcinoma after radiofrequency ablation therapy..J Chin Med Assoc2019;82:2-10

[15] Maluccio MA,Pi W,Kubal C.Survival in patients with hepatocellular carcinoma (HCC): a report of 1444 patients treated within a multidisciplinary program..J Clin Oncol2017;35:e15652-e15652

[16] Kamath PS,Malinchoc M,Therneau TM.A model to predict survival in patients with end-stage liver disease..Hepatology2001;33:464-70

[17] Sterling RK,Clumeck N,Correa MC.Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection..Hepatology2006;43:1317-25

[18] Mazzaferro V,Sposito C,Langer M.Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience..Liver Transpl2011;17:S44-57

[19] Kanda Y.Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics..Bone Marrow Transplant2013;48:452-8 PMCID:PMC3590441

[20] Hassan I.Improving survival in patients with hepatocellular carcinoma related to chronic hepatitis C and B but not in those related to non-alcoholic steatohepatitis or alcoholic liver disease: a 20-year experience from a national programme..Intern Med J2019;

[21] Wu KT,Lu LG,Zhang F-J.Hepatocellular carcinoma: clinical study of long-term survival and choice of treatment modalities..World J Gastroenterol2013;19:3649-57 PMCID:PMC3691025

[22] Zheng J,Gönen M,Kingham TP.Actual 10-year survivors after resection of hepatocellular carcinoma..Ann Surg Oncol2017;24:1358-66 PMCID:PMC5609806

[23] Chapman BC,Hosokawa PW,Overbey DM.Impact of facility type and surgical volume on 10-year survival in patients undergoing hepatic resection for hepatocellular carcinoma..J Am Coll Surg2017;224:362-72

[24] Shiina S,Arano T,Enooku K.Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors..Am J Gastroenterol2012;107:569-77 PMCID:PMC3321437

[25] Lee K,Yi NJ,Jang JJ.Prognosis of hepatocellular carcinoma after liver transplantation: comparative analysis with partial hepatectomy..J Pathol Transl Med2017;51:79-86 PMCID:PMC5282549